PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 1 month ago Annual financial and audit reports / Terms of availability of the annual financial report Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 1 month ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel Poxel annonce la mise à disposition de son Document d'Enregistrement Universel 2023 auprès de l'AMF pour l'exercice clos au 31 décembre 2023, incluant rapports financiers et sociaux AMF Maladies Métaboliques Document D'Enregistrement Universel Traitements Innovants Poxel
BRIEF published on 10/03/2024 at 18:35, 1 year 2 months ago Poxel annonce ses résultats financiers et stratégiques pour 2023 Résultats Financiers Biopharmaceutique TWYMEEG® Poxel OrbiMed
BRIEF published on 10/03/2024 at 18:35, 1 year 2 months ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 1 year 2 months ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 2 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 2 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 2 months ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 1 year 2 months ago POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024 Partenariats Trésorerie Ventes TWYMEEG® Poxel
BRIEF published on 09/09/2024 at 07:35, 1 year 2 months ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
Published on 12/05/2025 at 19:20, 18 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 53 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 18 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 38 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 23 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 18:58, 39 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 1 hour 22 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 1 hour 51 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 2 hours 20 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 20 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 27 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 27 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 39 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
